Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 2Phase NA 1Phase 4 1

Status

Completed 3

Sponsor Class

OTHER 1NIH 1NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 3

Conditions

Leukemia, Myeloid, Acute 49Leukemia 33Precursor Cell Lymphoblastic Leukemia-Lymphoma 26Leukemia, Myelomonocytic, Acute 11Leukemia, Monocytic, Acute 10Myelodysplastic Syndromes 7Leukemia, Erythroblastic, Acute 7Burkitt Lymphoma 7Lymphoma 6Leukemia, Megakaryoblastic, Acute 6Leukemia, Biphenotypic, Acute 6Myeloproliferative Disorders 4Dendritic Cell Sarcoma, Interdigitating 4Thrombocytopenia 3Lymphoma, Non-Hodgkin 3Leukemia, Promyelocytic, Acute 3Congenital Abnormalities 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Philadelphia Chromosome 2Neutropenia 2Lymphoma, Large-Cell, Immunoblastic 2Lymphoma, Large B-Cell, Diffuse 2Leukemia, Myelomonocytic, Chronic 2Leukemia, Basophilic, Acute 2Anemia, Refractory, with Excess of Blasts 2Thrombocythemia, Essential 1Primary Myelofibrosis 1Polycythemia Vera 1Neoplasms 1Lymphoma, T-Cell 1

Interventions

Tretinoin 10Arsenic Trioxide 10Methotrexate 7Busulfan 7Gemtuzumab 6Cytarabine 6Cyclophosphamide 6Peripheral Blood Stem Cell Transplantation 5Filgrastim 5fludarabine phosphate 4Idarubicin 4Tacrolimus 3Etoposide 3Daunorubicin 3Antilymphocyte Serum 3lintuzumab 2Topotecan 2Radiotherapy 2Mycophenolic Acid 2Mercaptopurine 2Cyclosporins 2Cyclosporine 2Bortezomib 2Azacitidine 2thymoglobulin 1tamibarotene 1sargramostim 1romidepsin 1merphos 1entinostat 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Leukemia, Promyelocytic, Acute × Daunorubicin × Clear all
NCT00005962 2023-06-22

Comparison of Three Treatment Regimens in Treating Patients With Relapsed or Refractory Acute Myelogenous Leukemia

Eastern Cooperative Oncology Group

Phase 2 Completed
Other hematologic neoplasm

Leukemia, Erythroblastic, Acute, Leukemia, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Promyelocytic, Acute, Leukemia, Myelomonocytic, Acute

NCT01253070 2022-08-04

Sorafenib Tosylate and Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia

National Cancer Institute (NCI)

Phase 2 Completed
54 enrolled 10 charts
Other hematologic neoplasm

Leukemia, Promyelocytic, Acute, Leukemia, Myelomonocytic, Acute

NCT00276601 2014-04-17

Combination Chemotherapy in Treating Patients With Acute Promyelocytic Leukemia

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Completed
Other hematologic neoplasm

Leukemia, Leukemia, Promyelocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡